Lawmaker: 60% Enrichment Indication of Enemies’ Failure to Distort Iran’s Scientific Power
TEHRAN (FNA)- A senior Iranian lawmaker lauded the country’s scientists for their capability to enrich uranium to the purity level of 60%, stressing that it showed the enemies’ failure to stop Iran’s scientific progress.
“60% uranium enrichment showed that the sabotage and terrorist acts of the Zionists and the arrogant powers cannot harm the scientific power of the Islamic Republic of Iran,” Mousavi Ahmadi told FNA on Saturday.
“60% enrichment showed that we are able to do whatever we determine and our enemies should be assured that enrichment of uranium to higher levels is accessible to us as easy as the 60% enrichment,” he added.
Mousavi Ahmadi said that the western countries should accept that they are facing a powerful Iran.
Iran’s Ambassador to the International Atomic Energy Agency announced on Sunday that the IAEA has verified and approved Iran's 60 percent uranium enrichment.
"The IAEA released a report to verify that on April 17 that Iran has started producing UF6 with 60 percent purity through feeding UF6 gas with 5 percent purity simultaneously to IR4 and IR6 chains in Natanz Enrichment Center," Qaribabadi also Iran’s Permanent Representative to Vienna-based International Organizations told reporters.
Head of Iran’s Atomic Energy Organization (AEOI) Ali Akbar Salehi said last week the country is producing 9 grams of uranium with 60% level of enrichment per hour.
“Currently, 9 grams of 60% enriched uranium is being produced per hour and 20% enriched uranium will also be produced at the same time," Salehi said.
The AEOI Chief stressed that the Iranian scientists’ success to achieve 60% enrichment “was a great step to implement parliament’s law approved in December to counter sanctions".
"We can produce uranium with any level of purity if needed", he emphasized.
Iran and the remaining signatories to 2015 nuclear deal are meeting in Vienna to try to remove the unilateral US sanctions imposed by former president Donald Trump three years ago after he abandoned the international accord.
The US is not allowed to participate in the discussions, but its representatives are reportedly held abreast of the negotiations down the hall by the Europeans.
The new talks come after an incident was reported at a part of the power network of the Natanz nuclear facility on April 11.
The incident at the power distribution network of Shahid Ahmadi Roshan facility in Natanz has been blamed on Israel. While Tel Aviv officials have made implicit confession of the terrorist attack, the Israeli state and private media have acknowledged Mossad's leading role in the attack.
Iranian officials have vowed retaliation against perpetrators, specially Israel.
Earlier, Qaribabadi slammed Israel as the main culprit behind the recent incident in Natanz nuclear facility, adding that the act of sabotage will not stop enrichment activities in the complex.
“The full responsibility for this act of sabotage lies with the Zionist regime of Israel and its supporters,” Qaribabadi said in a televised interview, adding the damaged IR-1 centrifuges would be replaced in no time with others capable of 50 percent more enrichment capacity.
He stressed that the latest generation of homegrown centrifuges would also be set up in the nuclear facility in the near future.
In a first move to show Iran's hardening stance in reaction to the terrorist attack on Natanz nuclear facility, the country declared that the Atomic Energy Organization of Iran (AEOI) will initiate preparatory steps to start enriching uranium to the 60% purity level.
"Upon an order by the President, the AEOI has been required to launch 60-percent uranium enrichment line under Article 1 of the Parliament Law on 'Strategic Action to Remove Sanctions' and protect the Iranian nation's interests," AEOI Spokesman Behrouz Kamalvandi told FNA.
He further added that the International Atomic Energy Agency has been informed of Iran's plan, and pointed out that the 60-percent enriched uranium is used in the production of Molybdenum to be used for the production of different types of radiomedicine, with applications in the treatment of patients including those with cardiac problems.